Ads
related to: macular degeneration treatment- Wet AMD FAQs
Get Answers To Frequently Asked
Questions About Wet AMD
- Appointment Tips
Get Tips And Useful Information
To Talk to your Retina Specialist
- Clinical Study Results
See The Results of A Clinical Study
To Learn More About This Treatment
- Financial Assistance
Learn About Financial Support
That May Be Available To You
- Wet AMD FAQs
Search results
Adverum Biotechnologies Reports Q1 2024 Results: A Detailed Look
Guru Focus· 1 day agoOn May 9, 2024, Adverum Biotechnologies Inc (ADVM, Financial), a trailblazer in gene therapy for ocular diseases, disclosed its financial outcomes for the first quarter of 2024 through its 8 ...
EyePoint Pharmaceuticals stock target cut, retains Buy rating By Investing.com
Investing.com· 5 days agoThe reduction follows a significant 43% drop in EyePoint's share value on Monday, which contrasted...
Skye Bioscience (NASDAQ:SKYE) Shares Down 1.8%
ETF DAILY NEWS· 3 days agoSkye Bioscience, Inc. (NASDAQ:SKYE – Get Free Report)’s stock price was down 1.8% during trading on Wednesday . The company traded as low as $12.32 and last traded at $12.50. Approximately 29,170 ...
Against Sunscreen Absolutism
The Atlantic· 2 days agoThe country’s predominantly white population has by far the world’s highest rate of skin cancer, and for years the public-health establishment has warned...
Ocular Therapeutix stock target cut, Buy rating kept By Investing.com
Investing.com· 4 days agoThe biopharmaceutical company, known for its eye care treatments, has recently disclosed its...
Nanoscope Therapeutics Announces Presentations in Upcoming ASGCT Annual Meeting and Retina World...
FOX 5 San Diego· 5 days agoDALLAS, May 7, 2024 /PRNewswire/ -- Nanoscope Therapeutics Inc., a late-stage clinical biotechnology company developing gene therapies for retinal degenerative diseases, today announced that ...
Outlook Therapeutics, Inc. (NASDAQ:OTLK) Receives $46.43 Average Target Price from Analysts
ETF DAILY NEWS· 1 day agoShares of Outlook Therapeutics, Inc. (NASDAQ:OTLK – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the eight research firms that are covering the firm, Marketbeat ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 3 days agoWilmington, Delaware, May 08, 2024 (GLOBE NEWSWIRE) -- Ophthalmic operating tables market is witnessing significant growth, owing to the rising prevalence of ophthalmic surgeries globally. With an increasing aging population and the prevalence
Head to Head Survey: Cognition Therapeutics (NASDAQ:CGTX) vs. Opthea (NASDAQ:OPT)
ETF DAILY NEWS· 7 days agoCognition Therapeutics (NASDAQ:CGTX – Get Free Report) and Opthea (NASDAQ:OPT – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the ...
Gut Bacteria Slip into the Eye
The Scientist· 3 days agoThe retina is layered with photoreceptors, a variety of other neurons, and protective and structural membranes, but retinal disorders can tamper with this delicate system. Mutations in the Crumbs ...
Ad
related to: macular degeneration treatment